Tamiflu: Breaking Down the Benefits and Limitations
Tamiflu, generically known as oseltamivir, is a key antiviral medication for treating and preventing influenza A and B. This drug, developed by Gilead Sciences and marketed by Roche, inhibits the neuraminidase enzyme, crucial for flu virus spread. Early administration—within 48 hours of symptom onset—shortens flu duration and severity, benefiting high-risk groups like the elderly and those with chronic conditions. Despite potential side effects like nausea, Tamiflu remains vital, though careful use is suggested to avoid antiviral resistance and assess efficacy concerns.
